Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
45.70
-0.06 (-0.13%)
At close: Nov 21, 2024, 4:00 PM
46.15
+0.45 (0.98%)
After-hours: Nov 21, 2024, 6:34 PM EST
Halozyme Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 154.32 | 118.37 | 234.2 | 118.72 | 147.7 | 120.18 | Upgrade
|
Short-Term Investments | 511.99 | 217.63 | 128.6 | 622.2 | 220.31 | 301.08 | Upgrade
|
Cash & Short-Term Investments | 666.31 | 336 | 362.79 | 740.92 | 368.01 | 421.26 | Upgrade
|
Cash Growth | 37.87% | -7.39% | -51.03% | 101.33% | -12.64% | 18.82% | Upgrade
|
Receivables | 285.74 | 234.21 | 231.07 | 90.98 | 97.73 | 59.44 | Upgrade
|
Inventory | 131.41 | 127.6 | 100.12 | 53.91 | 60.75 | 29.36 | Upgrade
|
Prepaid Expenses | 43.52 | 48.61 | 45.02 | 40.48 | 28.27 | 33.37 | Upgrade
|
Total Current Assets | 1,127 | 746.42 | 739.01 | 926.29 | 554.76 | 543.44 | Upgrade
|
Property, Plant & Equipment | 74.49 | 74.94 | 75.57 | 8.79 | 10.59 | 10.86 | Upgrade
|
Goodwill | 416.82 | 416.82 | 409.05 | - | - | - | Upgrade
|
Other Intangible Assets | 419.59 | 472.88 | 546.65 | - | - | - | Upgrade
|
Long-Term Deferred Tax Assets | - | 4.39 | 44.43 | 155.43 | - | - | Upgrade
|
Other Long-Term Assets | 80.15 | 17.82 | 26.8 | 13.91 | 14.57 | 11.58 | Upgrade
|
Total Assets | 2,118 | 1,733 | 1,842 | 1,104 | 579.92 | 565.87 | Upgrade
|
Accounts Payable | 12.4 | 11.82 | 17.69 | 1.54 | 1.93 | 6.43 | Upgrade
|
Accrued Expenses | 96.42 | 94.1 | 97.66 | 22.17 | 19.08 | 53.36 | Upgrade
|
Current Portion of Long-Term Debt | - | - | 13.33 | 89.42 | 397.23 | 19.54 | Upgrade
|
Current Portion of Leases | - | 6.58 | 2.1 | 2.28 | 1.4 | 2.29 | Upgrade
|
Current Unearned Revenue | - | - | - | 1.75 | 1.75 | 4.01 | Upgrade
|
Total Current Liabilities | 108.82 | 112.49 | 130.79 | 117.15 | 421.39 | 85.64 | Upgrade
|
Long-Term Debt | 1,504 | 1,499 | 1,493 | 787.26 | - | 383.05 | Upgrade
|
Long-Term Leases | 30.76 | 25.62 | 32.69 | 0.54 | 3.47 | 4.18 | Upgrade
|
Long-Term Unearned Revenue | - | - | - | 2.53 | 4.03 | 1.25 | Upgrade
|
Other Long-Term Liabilities | 9.65 | 12.1 | 15.47 | - | - | - | Upgrade
|
Total Liabilities | 1,665 | 1,649 | 1,672 | 907.48 | 428.88 | 474.11 | Upgrade
|
Common Stock | 0.13 | 0.13 | 0.14 | 0.14 | 0.14 | 0.14 | Upgrade
|
Additional Paid-In Capital | 61.89 | 2.41 | 27.37 | 256.35 | 625.48 | 695.07 | Upgrade
|
Retained Earnings | 397.63 | 90.55 | 143.22 | -58.91 | -474.59 | -603.68 | Upgrade
|
Comprehensive Income & Other | -6.94 | -9.28 | -0.92 | -0.62 | 0.02 | 0.24 | Upgrade
|
Shareholders' Equity | 452.7 | 83.81 | 169.8 | 196.95 | 151.05 | 91.77 | Upgrade
|
Total Liabilities & Equity | 2,118 | 1,733 | 1,842 | 1,104 | 579.92 | 565.87 | Upgrade
|
Total Debt | 1,535 | 1,531 | 1,541 | 879.49 | 402.1 | 409.06 | Upgrade
|
Net Cash (Debt) | -868.6 | -1,195 | -1,178 | -138.57 | -34.08 | 12.21 | Upgrade
|
Net Cash Growth | - | - | - | - | - | -94.65% | Upgrade
|
Net Cash Per Share | -6.69 | -8.91 | -8.38 | -0.94 | -0.24 | 0.08 | Upgrade
|
Filing Date Shares Outstanding | 127.23 | 126.82 | 135.37 | 137.7 | 135.21 | 138.01 | Upgrade
|
Total Common Shares Outstanding | 127.18 | 126.77 | 135.15 | 137.5 | 134.97 | 136.5 | Upgrade
|
Working Capital | 1,018 | 633.93 | 608.22 | 809.14 | 133.38 | 457.8 | Upgrade
|
Book Value Per Share | 3.56 | 0.66 | 1.26 | 1.43 | 1.12 | 0.67 | Upgrade
|
Tangible Book Value | -383.71 | -805.89 | -785.9 | 196.95 | 151.05 | 91.77 | Upgrade
|
Tangible Book Value Per Share | -3.02 | -6.36 | -5.81 | 1.43 | 1.12 | 0.67 | Upgrade
|
Machinery | 56.79 | 50.78 | 43.13 | 18.26 | 17.25 | 16.12 | Upgrade
|
Leasehold Improvements | 7 | 6.99 | 6.73 | 1.63 | 1.63 | 1.63 | Upgrade
|
Order Backlog | - | 76.8 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.